Dr. Sunir Joshi, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Drexel University College of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 141
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Drexel University College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
GA license 99037
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Thomas Eye Group PC (52 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 141
- Services billed
- 2,106
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Imaging of retina | 39 | 26 |
| Established patient complete exam of visual system | 29 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in Lithonia, GA | 159 |
| Combigan (brimonidine tartrate/timolol) Other prescribers in Lithonia, GA | 62 |
| Lumigan (bimatoprost) Other prescribers in Lithonia, GA | 32 |
| Prednisolone Acetate Other prescribers in Lithonia, GA | 22 |
| Rhopressa (netarsudil mesylate) | 18 |
| Timolol Maleate Other prescribers in Lithonia, GA | 18 |
| Dorzolamide Hcl Other prescribers in Lithonia, GA | 16 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Lithonia, GA | 13 |
| Restasis (cyclosporine) Other prescribers in Lithonia, GA | 12 |
| Ilevro (nepafenac) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 36 payments worth $9,928 in total to this clinician.
| Regeneron Pharmaceuticals, Inc. | $9,443 |
|---|---|
| Genentech USA, Inc. | $186 |
| AbbVie Inc. | $184 |
| Astellas Pharma US Inc | $39.50 |
| Regeneron Healthcare Solutions, Inc. | $30.20 |
| Dompe US, Inc. | $28.94 |
| Alcon Vision LLC | $16.58 |
| Consulting Fee | $7,713 |
|---|---|
| Travel and Lodging | $1,523 |
| Food and Beverage | $692 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $3,428 |
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $2,571 |
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,714 |
| Regeneron Pharmaceuticals, Inc. Jul 29, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $824 |
| Regeneron Pharmaceuticals, Inc. Aug 13, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $342 |
| Regeneron Pharmaceuticals, Inc. Aug 11, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $101 |
| Regeneron Pharmaceuticals, Inc. Aug 11, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $90.80 |
| Regeneron Pharmaceuticals, Inc. Aug 8, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $89.71 |
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $40.00 |
| Regeneron Pharmaceuticals, Inc. Jul 29, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TARRYTOWN, NY · in-kind | $35.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $226,378 in research payments for these studies, mostly to the institutions running them.
- Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
Regeneron Pharmaceuticals, Inc. · Completed · NCT04429503
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.